Investor Insight – Proteomics International’s predictive test for diabetic kidney disease successfully validated in major clinical study

“The results showed that patients predicted by PromarkerD to be at high-risk of chronic kidney disease were 13.5 times more likely than the low-risk group to develop the disease, with the results showing high statistical significance (p = 1.3 x 10^-104).“

Article: Proteomics International’s predictive test for diabetic kidney disease successfully validated in major clinical study